| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Diabetic Nephropathies | |||||
| Diabetes Type 1 | |||||
| Diabetes Type 2 | |||||
| Diabetic Kidney Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Diabetes Mellitus | |||||
| Diabetes Mellitus, Type 1 | |||||
| Diabetes Mellitus, Type 2 | |||||
| Kidney Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Autoimmune Diseases | |||||
| Diabetes Complications | |||||
| Endocrine System Diseases | |||||
| Glucose Metabolism Disorders | |||||
| Immune System Diseases | |||||
| Metabolic Diseases | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Pirfenidone | |||||
| 5 | More general drug interventions related to this trial | ||||
| Analgesics | |||||
| Analgesics, Non-Narcotic | |||||
| Anti-Inflammatory Agents | |||||
| Anti-Inflammatory Agents, Non-Steroidal | |||||
| Antineoplastic Agents | |||||
| Antirheumatic Agents | |||||
| Central Nervous System Agents | |||||
| Peripheral Nervous System Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Sensory System Agents | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | |||||
|
